These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 15558024)
1. Amiloride augments TRAIL-induced apoptotic death by inhibiting phosphorylation of kinases and phosphatases associated with the P13K-Akt pathway. Kim KM; Lee YJ Oncogene; 2005 Jan; 24(3):355-66. PubMed ID: 15558024 [TBL] [Abstract][Full Text] [Related]
2. Amiloride potentiates TRAIL-induced tumor cell apoptosis by intracellular acidification-dependent Akt inactivation. Cho YL; Lee KS; Lee SJ; Namkoong S; Kim YM; Lee H; Ha KS; Han JA; Kwon YG; Kim YM Biochem Biophys Res Commun; 2005 Jan; 326(4):752-8. PubMed ID: 15607733 [TBL] [Abstract][Full Text] [Related]
3. TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation. Kim YH; Lee YJ J Cell Biochem; 2007 Mar; 100(4):998-1009. PubMed ID: 17031854 [TBL] [Abstract][Full Text] [Related]
4. Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide-Akt-FLIP pathway. Nam SY; Amoscato AA; Lee YJ Oncogene; 2002 Jan; 21(3):337-46. PubMed ID: 11821946 [TBL] [Abstract][Full Text] [Related]
5. Role of HER-2/neu signaling in sensitivity to tumor necrosis factor-related apoptosis-inducing ligand: enhancement of TRAIL-mediated apoptosis by amiloride. Kim KM; Lee YJ J Cell Biochem; 2005 Oct; 96(2):376-89. PubMed ID: 16059913 [TBL] [Abstract][Full Text] [Related]
7. HER2 signaling downregulation by trastuzumab and suppression of the PI3K/Akt pathway: an unexpected effect on TRAIL-induced apoptosis. Dubská L; Andera L; Sheard MA FEBS Lett; 2005 Aug; 579(19):4149-58. PubMed ID: 16023111 [TBL] [Abstract][Full Text] [Related]
8. Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors. Aggarwal BB; Bhardwaj U; Takada Y Vitam Horm; 2004; 67():453-83. PubMed ID: 15110190 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release. Gibson EM; Henson ES; Haney N; Villanueva J; Gibson SB Cancer Res; 2002 Jan; 62(2):488-96. PubMed ID: 11809700 [TBL] [Abstract][Full Text] [Related]
10. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Sylvester PW; Shah S Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643 [TBL] [Abstract][Full Text] [Related]
11. Sensitization of mesothelioma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by heat stress via the inhibition of the 3-phosphoinositide-dependent kinase 1/Akt pathway. Pespeni MH; Hodnett M; Abayasiriwardana KS; Roux J; Howard M; Broaddus VC; Pittet JF Cancer Res; 2007 Mar; 67(6):2865-71. PubMed ID: 17363610 [TBL] [Abstract][Full Text] [Related]
12. Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells. Oka N; Nakahara S; Takenaka Y; Fukumori T; Hogan V; Kanayama HO; Yanagawa T; Raz A Cancer Res; 2005 Sep; 65(17):7546-53. PubMed ID: 16140916 [TBL] [Abstract][Full Text] [Related]
13. Selective Akt inactivation and tumor necrosis actor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxel. Asakuma J; Sumitomo M; Asano T; Asano T; Hayakawa M Cancer Res; 2003 Mar; 63(6):1365-70. PubMed ID: 12649200 [TBL] [Abstract][Full Text] [Related]
14. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. Ravi R; Bedi A Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014 [TBL] [Abstract][Full Text] [Related]
15. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP. Rokhlin OW; Guseva NV; Tagiyev AF; Glover RA; Cohen MB Prostate; 2002 Jun; 52(1):1-11. PubMed ID: 11992615 [TBL] [Abstract][Full Text] [Related]
16. eNOS protects prostate cancer cells from TRAIL-induced apoptosis. Tong X; Li H Cancer Lett; 2004 Jul; 210(1):63-71. PubMed ID: 15172122 [TBL] [Abstract][Full Text] [Related]
17. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex. Izeradjene K; Douglas L; Delaney AB; Houghton JA Cancer Res; 2004 Nov; 64(21):8036-44. PubMed ID: 15520213 [TBL] [Abstract][Full Text] [Related]
18. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K; Douglas L; Delaney A; Houghton JA Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death. Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504 [TBL] [Abstract][Full Text] [Related]
20. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Nimmanapalli R; Perkins CL; Orlando M; O'Bryan E; Nguyen D; Bhalla KN Cancer Res; 2001 Jan; 61(2):759-63. PubMed ID: 11212279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]